Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort.

By T. Young, L. Finn, Paul E. Peppard, M. Szklo-Coxe, Diane Austin, F. Nieto, R. Stubbs, K. Hla. Sleep, 2008

1,766 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. (2013, background): “Can OSA have independent effects on the CardioMetabolic Risk attributed to Obesity and Metabolic Syndrome? Clinical and epidemiological studies reported an independent association between OSA and cardiovascular events suggesting that OSA may lead to cardiometabolic dysregulation (16-18).”
Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: a randomized controlled trial. (2012, neutral): “CPAP pressure, median (IQR), cm H2O 8 (7-9) 9 (7-10) .”
Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of Hypertension (2012, methodology): “Patients with OSA were divided into 4 groups based on their CPAP treatment status: (1) ineligible for CPAP therapy according to the national guidelines, (2) eligible for CPAP therapy but declined, (3) started CPAP therapy but were nonadherent, and (4) treated with CPAP therapy.”
Increased prevalence of sleep-disordered breathing in adults. (2013, background): “The estimated increases translate to millions of additional afflicted persons in the United States, and, consequently, incidences of sequelae of SDB, such as cardiovascular morbidities and stroke (1, 33, 34), cognitive decline (4), depression (7), and premature death (8, 9), are likely accelerated r”